Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines against biologic agents: uses and developments.

Noel C Ales1, Rohit K Katial

  • 1Department of Allergy and Immunology, Walter Reed Army Medical Center, 6900 Georgia Avenue NW, Washington, DC 20307, USA.

Respiratory Care Clinics of North America
|April 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations Between Social Determinants of Health and Adherence to Biologic Therapies in Patients with Severe Asthma: Real-World Evidence from a Large US Claims Analysis.

Journal of asthma and allergy·2026
Same author

The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.

The journal of allergy and clinical immunology. Global·2026
Same author

Asthma remission in the context of other immune-mediated diseases.

The Journal of allergy and clinical immunology·2025
Same author

Current data on biologics: Evaluating clinical remission in asthma.

The Journal of allergy and clinical immunology·2025
Same author

Consensus summary on the definition of asthma remission.

The Journal of allergy and clinical immunology·2025
Same author

A critical look at the lexicon, parameters, and limitations of asthma remission definitions.

The Journal of allergy and clinical immunology·2025
Same journal

Indirect calorimetry: relevance to patient outcome.

Respiratory care clinics of North America·2006
Same journal

Indirect calorimetry: applications in practice.

Respiratory care clinics of North America·2006
Same journal

Strategies to prevent aspiration-related pneumonia in tube-fed patients.

Respiratory care clinics of North America·2006
Same journal

Feeding the critically ill obese patient: the role of hypocaloric nutrition support.

Respiratory care clinics of North America·2006
Same journal

Nutrition support for the long-term ventilator-dependent patient.

Respiratory care clinics of North America·2006
Same journal

A nutritional strategy to improve oxygenation and decrease morbidity in patients who have acute respiratory distress syndrome.

Respiratory care clinics of North America·2006
See all related articles

Vaccines are a hopeful therapy against bioterrorism agents, but challenges like rapid development, ethical concerns, and evolving threats necessitate concurrent research into disease management and treatment strategies. Proactive prophylaxis requires careful benefit-risk assessment for effective societal protection.

Area of Science:

  • Biodefense and Public Health
  • Infectious Disease Epidemiology
  • Medical Countermeasures

Background:

  • The Geneva Protocol's limited ratification allowed continued development of chemical and biologic weapons.
  • Healthcare professionals must develop strategies to protect society from devastating biologic agents.
  • Historical reliance on vaccination faces challenges due to the evolving nature of bioterrorism threats.

Purpose of the Study:

  • To evaluate the limitations of vaccination as the sole defense against bioterrorism.
  • To highlight the need for concurrent research in disease management and treatment.
  • To discuss the challenges in developing and deploying effective vaccines and chemoprophylaxis.

Main Methods:

  • Review of historical data and scientific literature on bioterrorism agents and countermeasures.

Related Experiment Videos

  • Analysis of the obstacles in vaccine development, testing, and deployment.
  • Examination of factors rendering vaccines ineffective, such as virulent strains and antibiotic resistance.

    • Main Results:

    • Vaccine development faces significant hurdles including time constraints, ethical considerations, and applicability of preclinical data to human disease.
    • Biologic agents can be engineered or presented in ways that overcome vaccine efficacy, including antibiotic and vaccine resistance.
    • Existing stockpiles and mass production capabilities for vaccines are inadequate, and policies for experimental vaccines are lacking.

    Conclusions:

    • Vaccination alone is insufficient to protect against bioterrorism; concurrent research into disease management and treatment is essential.
    • Mass vaccination is often impractical due to public resistance, side effects, and cost-benefit analyses.
    • Preemptive prophylaxis strategies, including vaccination for first responders, require careful benefit-risk assessment to protect society from unknown threats.